ARTICLE SUMMARY:
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Diagnostic Emergency Use Authorizations in January 2022. Updated January 31, 2022.
A roundup of FDA’s actions in January 2022.
Novel FDA Device Approvals, Breakthrough Designations, Class I Recalls, Warning Letters, and new Diagnostic Emergency Use Authorizations in January 2022. Updated January 31, 2022.
A roundup of FDA’s actions in January 2022.